BroadcastNovember 22, 2025FR
Outlet: BFM Business · Check-up Santé (Fabien Guez)
Tanel Petelot sur BFM Business pour parler santé mentale et psychiatrie
On BFM Business's Check-up Santé (hosted by Fabien Guez), Tanel Petelot laid out the gap between periodic psychiatric assessments and what patients actually experience between visits — and how Emobot's passive smartphone monitoring is designed to close it.
Read / watch →Feature articleNovember 2025FR
Outlet: Sciences et Avenir
Une IA pour suivre les variations d'humeur des patients dépressifs et bipolaires
Sciences et Avenir profiled Emobot's smartphone-based passive mood monitoring, with commentary from Pr. Fabien Vinckier (GHU Paris, Université Paris Cité, Institut du Cerveau) on how early detection of abnormal emotional variance between visits could be "very useful" for clinicians managing bipolar and depressed patients.
Read / watch →Press releaseOctober 2025FR
Outlet: Pfizer France · WILCO
Emobot selected for Season 5 of the Pfizer Healthcare Hub France
Pfizer France and WILCO selected Emobot as one of six startups for the 5th edition of the Pfizer Healthcare Hub France — a 9-month acceleration program. The collaboration extends Emobot's mood-monitoring platform to the follow-up of depression associated with chronic inflammatory diseases (MICI, psoriasis), opening a new indication beyond interventional psychiatry.
Read / watch →Feature articleSeptember 16, 2025FR
Outlet: Le Quotidien du Médecin (Aude Frapin)
Emobot : une IA pour suivre les variations d'humeur des patients dépressifs et bipolaires
In Le Quotidien du Médecin — France's reference daily for physicians — journalist Aude Frapin covered Emobot as a passive, smartphone-based mood monitor ("podomètre de l'humeur") designed to help psychiatrists catch relapse between the average 30-minute visit every two months, with a 120-doctor waiting list and 300+ patients already tracked.
Read / watch →Press releaseSeptember 8, 2025FR
Outlet: Ministère de la Santé · France 2030
France 2030 : Emobot parmi les 3 lauréats de l'appel à projets « Dispositifs médicaux numériques en santé mentale »
Minister Yannick Neuder named Emobot one of three national winners of the France 2030 call for projects on digital medical devices in mental health. The award funds the REMOOD clinical trial — designed to establish the clinical efficacy of Emobot's passive mood-monitoring device and to support the CE marking pathway.
Read / watch →Feature articleJuly 5, 2025EN
Outlet: VivaTech
6 Unmissable Startups at VivaTech 2025
VivaTech named Emobot one of six unmissable startups at its 2025 edition, highlighting the French-American company's AI-powered continuous mood monitoring and personalized digital therapy for the 280 million people living with mood disorders.
Read / watch →BroadcastJune 12, 2025EN
Outlet: Euronews
VivaTech: Mental health innovations take centre stage at Europe's largest tech fair
Euronews profiled Emobot at VivaTech 2025 as a French startup using AI to monitor mood disorders via smartphone throughout the day — what co-founder Antony Perzo described on camera as "a sort of thermometer for mental health."
Read / watch →InterviewApril 8, 2025FR
Outlet: Who's Who
5 Questions à Tanel Petelot (Emobot)
In the Who's Who founder interview series, Tanel Petelot answered five questions on Emobot's origin story, product vision, and the road from CentraleSupélec to deployment across US interventional psychiatry clinics.
Read / watch →ResearchJanuary 2025EN
Outlet: ICLR 2025
Emobot research accepted at ICLR 2025 (A* Conference)
Work from the Emobot research team on representation learning was accepted at the International Conference on Learning Representations — one of the three most selective AI research conferences in the world.
Read / watch →